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ABSTRACT
The study aimed to analyze the efficacy of Aeromonas hydrophila formalin-killed cells (FKC) and lipopolysaccharides 
(LPS) vaccines in maternal immunity of tilapia broodstock and the resistance of the offsprings. This study consisted 
of two consecutive studies. Firstly, the broodstocks were vaccinated with PBS (non-vaccinated), FKC, LPS, and 
combinations of  FKC and LPS. Secondly, the offsprings from both the vaccinated and non-vaccinated broodstock 
were vaccinated with the same vaccine for broodstock by immersion method. After vaccination, the offsprings were 
challenged with pathogenic A. hydrophila. Antibody level and lysozyme were measured in the broodstock, egg, and 
offsprings. In the first experiment, the result showed that vaccinated broodstock and their offsprings had delivered 
a significant antibody level and lysozyme activity compared with the control.  The highest relative percent survival 
(RPS) of offspring resulted from the combination of  FKC and LPS vaccinated broodstock at 5, 10, and 15 days 
post-hatching at 85.00%, 75.23%, and 67.56%, respectively.  The second experiment showed vaccinated offsprings 
produced from vaccinated broodstock had a higher RPS than the RPS of vaccinated offsprings which produced 
from non-vaccinated broodstock. In conclusion, vaccination that using a combination of FKC and LPS vaccine in 
broodstock potentially improved the maternal immunity and protect their offspring from A. hydrophila infection. 
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ABSTRAK
Penelitian ini bertujuan menganalisis efikasi vaksin formalin-killed cells (FKC) dan lipopolisakarida (LPS) A. 
hydrophila pada imunitas maternal induk ikan nila dan ketahanan benih yang dihasilkan. Dalam penelitian ini, 
terdapat dua penelitian. Pertama, induk ikan nila divaksin dengan PBS (non-vaksinasi), vaksin FKC, LPS, dan 
kombinasi vaksin FKC dan LPS. Benih selanjutnya diuji ditantang dengan menggunakan  patogen A. hydrophila 
pada 5, 10, dan 15 hari pasca menetas. Kedua, benih yang dihasilkan oleh induk yang telah divaksinasi dan induk 
yang tidak divaksinasi tersebut divaksin dengan vaksin yang sama seperti pada induk dengan metode imersi. 
Setelah vaksinasi, keturunan diuji tantang dengan patogen A. hydrophila. Tingkat antibodi dan lisozim diukur 
pada induk, telur, dan benih. Pada percobaan pertama, hasilnya menunjukkan bahwa induk yang divaksinasi 
dan benih menunjukkan tingkat antibodi dan aktivitas lisozim yang signifikan dibandingkan dengan kontrol. 
Persentase kelangsungan hidup relatif (RPS) tertinggi benih yang dihasilkan dari induk yang divaksinasi FKC 
dan LPS masing-masing pada 5,10, dan 15 hari pascatetas pada 85,00%; 75,23%; dan 67,56%. Percobaan kedua 
menunjukkan bahwa benih yang divaksinasi dari induk yang divaksin menunjukkan RPS yang lebih baik daripada 
benih yang divaksinasi dari induk yang tidak divaksin. Vaksinasi menggunakan kombinasi FKC dan LPS pada 
induk berpotensi meningkatkan kekebalan induk dan melindungi benih dari infeksi A. hydrophila.
Kata kunci: Aeromonas hydrophila, antibodi, imunitas induk, nila, vaksinasi
Original article DOI: 10.19027/jai.18.2.141-151
142 Rahma Mulyani et al.  / Jurnal Akuakultur Indonesia 18 (2), 141–151 (2019)
INTRODUCTION
Motile aeromonad septicemia (MAS) 
is a bacterial disease caused by Aeromonas 
hydrophila bacteria that is capable of attacking 
fish from fingerling to broodstock phase. This 
disease generally affects many freshwater fish 
species in tropical waters, one of which is tilapia 
Oreochromis niloticus (Rahmaningsih, 2012; Li 
et al., 2017). According to Dehghani et al. (2012), 
A. hydrophila bacteria live in freshwater as normal 
flora. A. hydrophila bacterium is capable of 
causing tissue swelling, stomach oedema, reddish 
body, necrosis, ulceration, and haemorrhagic 
septicemia in fish (Citarasu et al., 2011; Hardi & 
Pebrianto, 2012; Fu et al., 2014). 
The development of disease management in 
fish culture nowadays tends to use preventive 
principle, such as vaccines. Vaccines can induce 
specific and nonspecific immunity of fish, besides 
protecting fish from certain pathogens in the long 
term period. Vaccination combined with good 
cultural management system practices can prevent 
disease attacks (Barman et al., 2013; Sugiani 
et al., 2013; Aaby et al., 2014; Amrullah et al., 
2014). Fingerling quality stocked becomes one 
aspect that affects the success of tilapia culture 
(Nisaa et al., 2016). Vaccination given to larvae in 
preventing disease has not given maximum results 
due to body defense limitation system. Larvae 
have not been able to respond to the vaccine. 
Larvae have to withstand direct exposure to 
pathogenic bacteria in aquatic environments until 
the adaptive immune system is formed (Swain 
& Nayak, 2009; Zhang et al., 2013). Therefore, 
building immunity through maternal immune 
transfer in fish should be done to provide larval 
protection against pathogenic attacks as early as 
possible (Mingming et al., 2014; Zhang et al., 
2014). Maternal immunity transfer can establish 
broodstock specific and non‒specific immunity 
as well as providing protection to the offspring 
produced against A. hydrophila bacterial infection 
(Sukenda et al., 2017).  
Some types of vaccine candidates from 
A. hydrophila intact bacterial cell supplies, 
such as formalin‒killed cell (FKC) and 
lipopolysaccharides (LPS) have been used to 
prevent A. hydrophila (Dehghani et al., 2012). FKC 
is a vaccine from A. hydrophila bacterial intact 
cell containing bacteria and proteins by bacterial 
inactivation using BNF 3%. The results reported 
that FKC vaccine applied to tilapia broodstock 
gave RPS value 78.26% on day five to the offspring 
after challenged with A. hydrophila (Sukenda 
et al., 2017), while lipopolysaccharides were a 
molecular constituent of Gram-negative bacterial 
outer membranes that are toxic to fish, making 
the bacteria become virulent. This molecule is 
amphiphilic and composed of oligosaccharides, 
polysaccharides, O‒antigen, and lipid‒A in the 
form of acetylglucosamine phosphate fatty acid 
(Merino et al., 2015). LPS in bacteria are able to 
provide an immunomodulatory effect on the host 
(Dehghani et al., 2012). 
The general purpose of this study was 
to determine effective vaccine substance 
between LPS, FKC, and combined LPS and 
FKC vaccine from A. hydrophila for motile 
aeromonas septicemia (MAS) prevention on 
tilapia fingerling. The specific purposes were to 
testify the main immunogenicity of vaccinated 
broodstock and offspring produced, fingerling 
protection and immunogenicity condition from 
vaccinated broodstock, and fingerling protection 
from vaccinated and unvaccinated broodstock. 
METHODS
Research design
The study design consisted of two consecutive 
studies. The first study was female broodstock 
vaccination and the second study was offspring 
vaccination on day 20 of rearing from broodstock 
spawning on the first study. 
Research procedures
Vaccine supply test
A vaccine tested in this study was formalin-
killed cells (FKC) and lipopolysaccharides (LPS) 
vaccine supply from A. hydrophila bacteria. FKC 
vaccine or whole-cell vaccine was created by A. 
hydrophila inactivation using buffered neutral 
formalin (BNF) 3%. The generated whole-cell 
vaccine of A. hydrophila referred to Sugiani et 
al. (2013). A. hydrophila bacteria was cultured in 
trypticase soy broth (TSB) medium and incubated 
with shaker for 24 hours at 28°C. Total of bacteria 
in the culture medium was calculated using total 
plate count (TPC) method. The result of bacterial 
culture (109 CFU/mL) was inactivated by adding 
BNF 3% of culture medium volume and incubated 
for 24 hours at 28°C. Inactivated bacterial cell 
was harvested by centrifugation method with 
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5000 rpm for 30 minutes. Supernatant created 
was subsequently taken and washed twice using 
sterile phosphate-buffered saline (PBS). Washed 
supernatant was resuspended to the initial volume 
using sterile PBS. 
After vaccine produced, viability test was 
done by streaking the vaccine candidate into TSA 
medium. Vaccine candidate that showed no growth 
was safe to be used. LPS vaccine was made based 
on Fernandez et al. (2014). A. hydrophila isolate 
was cultured in TSB media as much as 50 mL 
and incubated for 24 hours at 28oC. The result of 
bacterial culture (109 CFU/mL) was centrifuged 
at 1600 rpm for 20 minutes and injected with PBS 
ten times of product volume generated. Bacterial 
cells were heated for two hours at 100°C. 
Bacterial cells were centrifuged and discarded 
the supernatant. Bacterial cells were suspended 
in ethyl alcohol 95% ten times of cell liquidity 
and incubated at 37oC for 4 hours. Bacterial cells 
were washed with acetone and resuspended to 
the initial volume with PBS. After the vaccine 
production is completed, the viability test was 
done by streaking the vaccine candidate solution 
to trypticase soy agar (TSA). Vaccine candidate 
that showed no growth was safe to be used.
First study
Tilapia broodstock vaccination and spawning 
Female tilapia nirwana strain weighing 197 
± 14.9 g vaccination was done after one week 
of ovulation period or at gonad maturation level 
two (TKG2) (Nisaa et al., 2016). The vaccine 
was injected intraperitoneally with 109 CFU/
mL concentration at 0.4 mL/kg fish doze. 
Treatments applied were the injection of PBS 
(control), FKC vaccine, LPS vaccine, and 50:50 
(V/V) combination of FKC and LPS (GAB). 
Natural spawning ratio between male and female 
broodstock was 1:3 conducted in a concrete tank 
with 2.5×2.5×1 m3 size.
Tilapia offspring challenge test
Tilapia offspring challenge test was done by 
soaking the offspring into the solution containing 
A. hydrophila at the age of 5, 10, and 15 days after 
hatching with 107 CFU/mL concentration for 30 
minutes. The percentage of mortality and relative 
percent survival (RPS) on each treatment with 
three times replication were calculated on the 
seventh day after vaccination. 
Serum preparation sample from broodstock, egg 
liquid, and offspring body
Serum samples in this study were obtained by 
taking blood from the broodstock through the tail-
end veins. Serum was collected by centrifuged 
5000 rpm for 10 minutes at 4°C. Serum was 
separated into the microtube and stored at -20°C 
for antibody and lysozyme test. Eggs were taken 
after broodstock spawning, while the offspring 
samples were taken on 5, 10, 15, and 20 days 
after hatching. Ten eggs and five offsprings were 
homogenized each in PBS-T (PBS + 0.05% 
Tween-20) solution with 1:4 (g/v) ratio. Egg and 
offspring sample was centrifuged in 5000 rpm for 
10 minutes at 4°C. The supernatant was separated 
into microtube and stored at -20°C for antibody 
and lysozyme level test. 
Second research
Fingerling vaccination 
Second stage vaccination from the first study 
on fingerling aged 20 days after hatching with 
K+ (unvaccinated fingerling from unvaccinated 
broodstock), K+FKC (unvaccinated fingerling 
from FKC vaccinated broodstock), K+LPS 
(unvaccinated fingerling from LPS vaccinated 
broodstock), K+GAB (unvaccinated fingerling 
from GAB vaccinated broodstock), FKC (FKC 
vaccinated fingerling from FKC vaccinated 
broodstock), LPS (LPS vaccinated fingerling 
from LPS vaccinated broodstock), and GAB 
(GAB vaccinated fingerling from GAB vaccinated 
broodstock). Fingerling weighing 0.16 ± 0.021 g 
was soaked in vaccine solution with 107 CFU/mL 
for 30 minutes as much as 20 fingerlings on each 
treatment replicated three times. 
Tilapia fingerling challenge test
Tilapia fingerling reared for 11 days after 
vaccination was challenged with A. hydrophyla 
(107 CFU/mL) by soaking the fingerlings into 
the media containing a bacterial solution for 30 
minutes. Soaked fingerlings were reared in an 
aquarium sized 30×20×20 cm3 with 20 fingerlings 
in each aquarium. The percentage of mortality 
and relative percent survival (RPS) on fingerlings 
were calculated on 7 days after the challenge test.
Fingerling body liquid preparation
Fingerling body liquid was obtained from 
fingerlings in each treatment collected on 11 
days after vaccination. Five fingerlings were 
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homogenized in PBS-T (PBS + 0.05% Tween-20) 
solution at 1:4 (g/v) ratio. Fingerling samples 
obtained were centrifuged in 5000 rpm for 10 
minutes at 4°C. The supernatant was separated 
into a microtube and stored at -20°C for antibody 
and lysozyme level test.
Parameter
Relative percent survival (RPS)
Relative percent survival (RPS) was calculated 
using the following formula: 
Fingerling mortality rate
ELISA (Sigma) (TMB 5 mg + 10 µl H2O2 38% in 5 
mL buffer acetate pH 5), while blanko was added 
50 μL H2SO4 3 M into the first well of microplate 
and incubated for 20 minutes at 25°C. ELISA 
reaction was stopped by adding 50 μL H2SO4 3 M 
into the well. Optical density (OD) of microplate 
was read using microplate reader (Kayto RT-
2100C) on 450 nm absorbance. Antibody level 
was expressed in OD value.
Lysozyme activity
Lysozyme level on broodstock, egg, and 
fingerling was determined using the method 
of Hanif et al. (2005). Egg and fingerling body 
liquid as much as 100 µl were added with the 
liquid suspension of Micrococcus lysodeikticus 
(Sigma) as much as 100 µl (0.4 mg/mL in PBS 
pH 6.2) at 25°C.  Lysozyme level was read using 
microplate reader (Kayto RT-2100C) with 450 
nm absorbance for 30 seconds and 30 minutes 
mixing. The lysozyme activity unit was measured 
by decreased OD value of 0.001 per minute. 
Lysozyme activity was formulated below:
Fingerling mortality rate was calculated after 
challenged with A. hydrophila using the following 
formula: 
Antibody 
Broodstock, egg, and fingerling antibody level 
were measured using indirect enzyme-linked 
immunosorbent assay (ELISA) method (Sumiati 
et al., 2015). Antigen concentration was measured 
using Bradford spectrophotometry method. A 
total of 100 μL antigen that has been diluted 1:1 
using PBS (pH 7.2) was inserted in microplates 
well added with 100 μL carbonate-bicarbonate 
buffer (pH 9.6) on each well. Antigen was 
incubated at 4oC for 12 hours. Well was washed 
using PBS-T (PBS pH 7.4 + 0.05% Tween-20) 
and added with 100 μL bovine serum albumin 
(BSA, Sigma) 3% (w/v) in H2O, then incubated at 
25oC. The mixture was incubated for an hour and 
washed using PBS-T solution.
Broodstock blood serum was diluted in PBS-T 
(pH 7.2) 1:50 (v/v) solution, while egg and body 
liquid were diluted in PBS-T (pH 7.2) solution 
1:16, then inserted into the microplates as much 
as 100 μL with three replications and incubated 
for an hour at 25°C, then washed using PBS-T. 
Long-chain anti-tilapia immunoglobulin for 
polyclonal specific antibody was diluted in PBS-T 
solution 1:200 and added as much as 100 μL to 
each microplate, then incubated for an hour at 
25°C and washed using PBS-T solution twice. 
Subsequently, peroxidase-conjugated rabbit anti-
rabbit (Sigma) was diluted in PBS-T to 1:5000 as 
much as 100 μL was added to each microplate 
well. The microplate was incubated at 25oC for an 
hour and washed. 100 μL one step Ultra TMB-
Data analysis
This study used a completely randomized 
design method. Data obtained was collected 
using Microsoft Office Excel 2010 and analyzed 





Mortality rate and relative percent survival (RPS) 
value on tilapia offspring
The mortality rate of offspring in GAB 
vaccinated broodstock treatment was lower than 
the control treatment and LPS on the fifteenth 
day, but offspring from GAB treatment did not 
differ significantly (P>0.05) with FKC treatment 
on the fifteenth day. RPS value of GAB and FKC 
treatment on offspring also showed no significant 
difference (P>0.05), but showing a significant 
difference to the control treatment on the fifteenth 
day. Mortality rate and RPS value are presented 
in Table 1. 
Rahma Mulyani et al.  / Jurnal Akuakultur Indonesia 18 (2), 141–151 (2019) 145
Antibody and lysozyme level of tilapia egg and 
broodstock 
Antibody level of the egg (A) from FKC (OD: 
0.56) and GAB (OD: 0.58) vaccinated broodstock 
treatment were higher than control and LPS 
treatment. Lysozyme activity of eggs (B) from 
FKC (76.22 units/ml) and GAB (75.88 units/
ml) vaccinated broodstock showed different level 
from control and LPS, but the lysozyme activity 
of egg from LPS (39.11 unit/ml) vaccinated 
broodstock was higher than control treatment 
(25.51 units/ml). Antibody level formed after 
broodstock vaccination affected the antibody 
level of offspring generated from fifth to the 
fifteenth day. Offspring from treated broodstock 
showed decreased antibody level from fifth to the 
twentieth day (Figure 1). 
GAB treatment (OD: 0.36−0.52) had the 
highest antibody level of offspring compared to 
control (OD: 0.29−0.26) and other treatments 
on the twentieth day. Lysozyme activity of 
broodstock vaccinated with GAB (117.77 unit/
ml) and FKC (122.32 unit/ml) was higher than 
other treatments. Lysozyme activity (B) on 
control and LPS treatment of broodstock showed 
no difference. Offspring from treated broodstock 
Table 1. Mortality rate and RPS value on offspring 5, 10, 15 days after hatching 
Offspring age (day after hatching) Treatment Mortality (%) RPS (%)
5 Control 70.00 ± 5.00c -
FKC 15.00 ± 2.88ab 77.77 ± 5.87ab
LPS 25.00 ± 5.00b 65.00 ± 5.00a
GAB 10.00 ± 2.88a 85.00 ± 5.35b
10 Control 73.33 ± 1.66c -
FKC 20.00 ± 5.77a 72.69 ± 7.72b
LPS 36.66 ± 1.66b 50.00 ± 1.92a
GAB 18.33 ± 6.00a 75.23 ± 7.79b
15 Control 76.66 ± 3.33c -
FKC 26.00 ± 3.33a 65.47 ± 4.39b
LPS 41.66 ± 4.40b 45.83 ± 4.16a
GAB 25.00 ± 2.88a 67.56 ± 2.64b
Note: Different superscript letter on the same column shows significant different treatment (Duncan test; P<0.05). 
K+ (unvaccinated fingerling from unvaccinated broodstock), K+FKC (unvaccinated fingerling from FKC vaccinated 
broodstock), K+LPS (unvaccinated fingerling from LPS vaccinated broodstock), K+GAB (unvaccinated fingerling 
from GAB vaccinated broodstock), FKC (FKC vaccinated fingerling from FKC vaccinated broodstock), LPS 
(LPS vaccinated fingerling from LPS vaccinated broodstock), and GAB (GAB vaccinated fingerling from GAB 
vaccinated broodstock). 
Table 2. Mortality rate and RPS value of fingerling after vaccination 
Treatment Mortality (%) RPS (%)
K- 75.00 ± 2.88c -
K+FKC 56.66 ± 4.40b 24.50 ± 4.48a
K+LPS 65.00 ± 2.88cd 12.60 ± 6.84a
K+GAB 55.00 ± 2.88a 26.60 ± 3.39a
FKC 33.33 ± 6.00a 56.00 ± 6.24bc
LPS 43.33 ± 3.33a 41.95 ± 4.92b
GAB 31.66 ± 1.66a 57.79 ± 1.13c
Note: Different superscript letter on the same column shows significant different treatment (Duncan test; P<0.05). 
K+ (unvaccinated fingerling from unvaccinated broodstock), K+FKC (unvaccinated fingerling from FKC vaccinated 
broodstock), K+LPS (unvaccinated fingerling from LPS vaccinated broodstock), K+GAB (unvaccinated fingerling 
from GAB vaccinated broodstock), FKC (FKC vaccinated fingerling from FKC vaccinated broodstock), LPS 
(LPS vaccinated fingerling from LPS vaccinated broodstock), and GAB (GAB vaccinated fingerling from GAB 
vaccinated broodstock).
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Figure 1. Antibody level of broodstock (A), egg (B), and offspring (C), lysozyme activity of egg (D), broodstock 
(E), and offspring (F) on each treatment
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had decreased antibody level on the fifth to the 
twentieth day. Lysozyme activity of offspring 
from GAB treatment (70.22 units/ml) had the 
highest lysozyme activity compared to other 
treatments on fifth to twentieth day. Lysozyme 
activity of offspring from FKC and LPS treatment 
had significant different value compared to LPS 
and control (Figure 1).  
Second study
Mortality rate and relative percent survival value 
of tilapia fingerling after vaccination
Mortality rate of GAB vaccinated fingerling 
was the lowest value among other treatments. 
Mortality rate of fingerling on negative control and 
unvaccinated treatments (K+GAB, K+FKC, and 
K+LPS) significantly showed the highest value 
(P<0.05) (Table 2). RPS value of positive control 
fingerling on FKC, LPS, and GAB vaccinated 
broodstock treatment did not significantly differ 
(P>0.05), however, differed significantly (P<0.05) 
against FKC, LPS, and GAB vaccination on 
fingerling treatment. LPS and FKC vaccination 
on fingerling did not show a significant difference, 
while GAB treatment had a significant difference 
in RPS value (P<0.05) with LPS. 
Antibody level of fingerling after vaccination
GAB treatment showed a significant 
difference (P<0.05) against K-, K+LPS, 
and K+FKC treatment. Fingerling on the 
negative control (unvaccinated fingerling from 
unvaccinated broodstock), K+LPS, K+FKC, 
K+GAB (unvaccinated fingerling from LPS, 
FKC, and GAB vaccicated broodstock), and LPS 
treatment did not show the significantly different 
result (P>0.05) (Figure 2). Lysozyme activity of 
fingerling after vaccination on each treatment 
differed significantly with K‒ treatment. 
Lysozyme activity after FKC (48.66 units/ml) 
and GAB (49.66 units/ml) vaccination had no 
significant difference, but higher than other 
treatments. Positive control treatment on each 
vaccination treatment also showed significant 




Results showed that vaccinations on tilapia 
broodstock using formalin-killed cells (FKC) 
and lipopolysaccharides (LPS) vaccine gave 
a significantly better effect on the maternal 
immunity transfer from broodstock to offspring. 
Study on broodstock vaccination was able to 
Figure 2.   Antibody level (A)  and lysozyme activity (B) of fingerling on each treatment. K+ (unvaccinated 
fingerling from unvaccinated broodstock), K+FKC (unvaccinated fingerling from FKC vaccinated broodstock), 
K+LPS (unvaccinated fingerling from LPS vaccinated broodstock), K+GAB (unvaccinated fingerling from GAB 
vaccinated broodstock), FKC (FKC vaccinated fingerling from FKC vaccinated broodstock), LPS (LPS vaccinated 
fingerling from LPS vaccinated broodstock), and GAB (GAB vaccinated fingerling from GAB vaccinated 
broodstock).
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increase specific and nonspecific immunity, 
besides decreasing the mortality rate of fish 
offspring after challenge test (Swain et al., 2006; 
Mingming et al., 2014; Nisaa et al., 2016; Sukenda 
et al., 2017). Mortality percentage of offspring 
on 5,10, and 15 days after hatching obtained the 
highest rate at the control treatment, which was 
significantly different from offspring produced 
by vaccinated broodstock (P<0.05). This suggests 
that the vaccination treatment is able to provide 
protection as a passive immunity to the offspring 
better than other treatments, while mortality rate 
and RPS values of offspring from vaccinated 
broodstock showed that FKC and GAB treatment 
was better than the control treatment. This 
suggests that offspring produced from vaccinated 
broodstock is able to increase the immunity 
system, thus making them more resistant to 
A. hydrophila bacterial infection. In addition, 
vaccination on the broodstock before spawning 
gives an advantage to the offspring produced as 
it was able to suppress the mortality rate after 
challenged with A. hydrophila bacteria compared 
to offspring from unvaccinated broodstock. The 
same study result was reported by Sukenda et 
al. (2017), who stated that A. hydrophila whole-
cell vaccine given to tilapia broodstock was able 
to suppress mortality rate on the offspring with 
78.26% RPS value on 5 days after hatching. 
Another study showed that vaccinated offspring 
using FKC and GAB showed a good value of RPS 
(Sukenda, 2018). According to Swain and Nayak 
(2009), sustaining fish broodstock immunity at 
high level during vitellogenesis and oogenesis 
processes was important to suppress mortality 
rate on the larval phase or post-larvae through the 
maternal immunity transfer. Higher RPS value 
in GAB treatment than control treatment was 
also supported by antibody level and lysozyme 
activity data.
Results on the antibody level of broodstock 
after vaccination differed significantly compared 
to the control treatment (P<0.05). This suggests 
that vaccination to the broodstock will induce 
antibody level compared to the unvaccinated 
broodstock. Antibody level was a parameter 
for determining the specific immune response 
formed. Antibody level of vaccinated broodstock 
will be formed in the body one week after 
vaccination (Sukenda et al., 2018). The antibody 
in high concentration could be obtained from fish 
serum (Magnadottir, 2010). Antibody level in egg 
and offspring after vaccination were higher than 
control or unvaccinated treatment. The presence 
of antibody found in the egg was obtained from 
the maternal immunity transfer of the vaccinated 
parent (Nisaa et al., 2016). The presence of 
antibody in offspring plays an important role in 
protecting the larvae against environmental and 
pathogenic influences due to the limited capacity 
of offspring immune system (Vadstein et al., 
2013). The cause of high-level antibodies in egg 
and offspring vaccination using FKC and GAB 
was the availability of more antigen in intact cells 
compared to LPS. In addition to LPS vaccine, A. 
hydrophila cell component is antigenic bacteria 
that can elicit an immune response as a protein 
(Lacerda et al., 2015). 
Antibody level observed from vaccinated 
broodstock serum showed higher results compared 
to unvaccinated broodstock. The same result was 
reported by Sukenda et al. (2017), who stated that 
vaccinated broodstock with A. hydrophila a whole-
cell vaccine was able to significantly increase the 
antibody level. Nisaa et al. (2016) and Pasaribu et 
al. (2018) also reported that the antibody level of 
broodstock after vaccination using Streptococcus 
agalactiae or bivalent vaccine of S. agalactiae 
and A. hydrophila increased compared to control 
treatment. The antibody was also found in the egg 
from vaccinated broodstock as allegedly because 
of the immunoglobulin transfer by broodstock 
naturally that was metabolized together with the 
yolk (Zhang et al., 2013).
In the gonad maturation process, environmental 
signals are received by the central nervous 
system and transmitted to the hypothalamus. 
Hypothalamus will release gonadotropin-
releasing hormone (GnRH) which works in 
the pituitary gland. Pituitary releases FSH that 
works on theca cell and synthesizes testosterone. 
Granulosic layer that contains aromatase enzyme 
will convert testosterone into 17β-estradiol which 
stimulates the liver to synthesize vitellogenin 
(prospective yolk). Vitellogenin is carried by the 
bloodstream and absorbed by the follicle oocytes 
enlarged to the maximum size for vitellogenesis 
process. The pathway of this vitellogenesis 
process has the specific (antibody) and nonspecific 
(lysozyme) immunity to enter into the yolk to 
be transferred to the offspring (Swain & Nayak, 
2009; Wang et al., 2011).
Nisaa et al. (2017) reported that tilapia 
fingerling antibody level originated from 
vaccinated broodstock decreased slowly until 28 
days after hatching. The mechanism of antibody 
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formation after vaccination is caused by the 
contact between the antigen and lymphocytes (B 
cell and T cell). the antigen in the vaccine can 
directly induce the proliferation of B cell into the B 
memory cell and plasma cell. B memory cell will 
store the information about antigen characteristics 
entering the body, while the plasma cells will 
produce a specific antibody for antigen. An antigen 
that enters the body can also be phagocytized by 
macrophages. After phagocytized, the antigen 
will be exposed to T-helper cells through major 
histocompatibility complex (MHC) protein class 
II. T helper cells are activated by macrophages 
via cytokine molecules. Activated T-helper cells 
will produce cytokines that stimulate B cell, T 
memory cells, and cytotoxic T cells. When the 
same antigen exposure occurs for the second 
time, the T memory cell will stimulate B memory 
cell to proliferate into plasma cells and produce 
antibody (Reece et al., 2014).
The non‒specific immune parameter is the 
lysozyme activity. Lysozyme activity is one of the 
bacteriolytic enzymes produced in lysosomes as 
phagocytes of fish body natural defense response 
during infection (Akbary et al., 2015; Wang & 
Zhang, 2010).  Lysozyme activity of broodstock 
vaccinated with GAB (117.77 units/ml) and FKC 
(122.32 units/ml) increased significantly and were 
higher (P<0.05) than other treatments. 
Swain and Nayak (2009) explained that 
vaccination improves non-specific and specific 
immune responses. Lysozyme is usually found 
in serum, homogenic seed, and mucous liquid 
as well as part of the fish body undergoing 
infection due to pathogenic attacks, such as 
skin and gills. Lysozyme acts in opsonization 
process that demonstrates the main inflammatory 
response due to the activation of the complement 
system and phagocytosis (Sugiani et al., 2012). 
The lysozyme activity of eggs and offspring 
also highly increased in the spawning process 
of vaccinated broodstock compared to egg 
and offspring produced from unvaccinated 
broodstock. Lysozyme activity has been found 
in egg and offspring because basically lysozyme 
appeared before, briefly, and after hatching to give 
immunity to fish fingerling (Magnadottir, 2006). 
Lysozyme activity on offspring from FKC, LPS, 
and GAB decreased on the tenth day and increased 
on the fifteenth day along with the offspring age. 
This was different from the lysozyme activity 
of offspring from broodstock control vaccine 
treatment that continued to increase from fifth 
to the twentieth day. Furthermore, lysozyme 
activity of fingerling after vaccination on positive 
control and vaccinated broodstock treatment did 
not differ significantly. However, FKC and GAB 
vaccination differed significantly with other 
treatments. Increased lysozyme activity of eggs 
and fingerlings was associated with the maternal 
immunity transfer from broodstock and induced 
the development of lymphoid organs such as 
kidneys, thymus, and spleen as increased immune 
transfer factor derived from broodstock (Swain & 
Nayak, 2009).
CONCLUSION
Vaccination using combined formalin-killed 
cells (FKC) and lipopolysaccharides (LPS) 
vaccine of A. hydrophila is able to provide 
induced maternal immunity to the offspring 
produced.  Offspring immunity at the growth 
beginning was found in the offspring produced 
from vaccinated broodstock using combined FKC 
and LPS vaccine. Fingerling vaccination from 
vaccinated broodstock using combined FKC and 
LPS vaccine of A. hydrophila showed the best 
RPS value with 57.79%.
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